Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
Titel:
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
Auteur:
Dummer, Reinhard Schadendorf, Dirk Ascierto, Paolo A Arance, Ana Dutriaux, Caroline Di Giacomo, Anna Maria Rutkowski, Piotr Del Vecchio, Michele Gutzmer, Ralf Mandala, Mario Thomas, Luc Demidov, Lev Garbe, Claus Hogg, David Liszkay, Gabriella Queirolo, Paola Wasserman, Ernesto Ford, James Weill, Marine Sirulnik, L Andres Jehl, Valentine Bozón, Viviana Long, Georgina V Flaherty, Keith